Yantai Changyu Pioneer Wine-A:UBS Evidence Lab reveals a strong brand but execution risk could cap near-term growth

类别:公司研究 机构:瑞银证券有限责任公司 研究员:Anne Huang 日期:2016-06-20

Leading wine producer in China; initiating with a Neutral rating

    We believe Changyu could benefit from a structural industry recovery and afragmented landscape due to its competitive advantages in brand recognition andnationwide distribution channels. However, we see execution risk exists regarding itsshift to a more diversified product mix strategy. The stock is trading at 24/3x 2017PE/PB, in line with industry peers and slightly higher than its historical average.

    Changyu could benefit from an industry recovery and consolidation

    UBS Evidence Lab survey showed Changyu has high brand awareness, purchasing andloyalty. Our proprietary survey also found greater wine consumption intent, led by midtiercity penetration and wealthy, mature male respondents. We forecast rising massmarketwine consumption to drive robust volume growth, while its average selling price(ASP) could be flattish, with consumption upgrade trend offset by intensifyingcompetition. Despite Changyu's high brand recognition, it only has 3% market share inthe mid- to low-end wine segment. We estimate the mid- to low-end segmentaccounts for 90% of total industry sales volume and is occupied by small players.

    Meanwhile, a number of overseas companies are entering an adjustment period tobuild brands and channels in China, which suggests Changyu could benefit fromsizeable consolidation potential, given its competitive brand and channel advantages.

    Execution risk could cap near-term growth

    We believe Changyu could face execution risk as: 1) it is changing its growth model byshifting towards a more diversified product mix strategy from one driven by highmarginproducts, suggesting potential conflicts of interest in resource re-allocation; and2) our economic analysis on imported wine suggests that Jiebaina (Changyu's bestsellingproduct) and its mid- to low-end products could face intensifying competition,while UBS Evidence Lab showed consumers generally believe international brands havebetter quality and are willing to pay a 20-30% premium. We forecast Changyu willslightly gain market share in the wine segment in the next 3 years, mainly due to midtolow-end products. We expect Changyu's margin to continue declining, mainly due toa product mix downgrade and further brand/channel investment.

    Valuation: Rmb40.09 DCF-based price target and Neutral rating

    We believe Changyu is fairly valued compared with its historical average and industrypeers. We forecast 2016-18 EPS at 1.58/1.66/1.75. Our DCF-based price target ofRmb40.09 (WACC 7.0%) implies 25x/24x 2016/17E PE.

股票代码 股票名称 最新价(元) 涨跌额(元) 涨跌幅(%) 成交额(万元) 成交量(手)
000869 @nn@ @n@ @c@ @cc@ @v@ @t@

数据推荐

投资评级

更多>>
股票名称最新评级目标价研报

盈利预测

评级选股>>
股票名称11年EPS12年EPS研报
绿地控股 0.55 0.30 研报
新城控股 0 0 研报
光大嘉宝 0.60 0 研报
世联行 0.84 0.62 研报
大悦城 0.30 0.27 研报
蓝光发展 0.24 0 研报
荣盛发展 0.75 1.04 研报
金科股份 1.15 1.24 研报
中南建设 0.80 0.99 研报
金融街 0.64 0.72 研报
新湖中宝 0.38 0.32 研报

股票关注度

更多>>
股票名称关注度平均评级最新评级
海康威视 6 持有 买入
华夏幸福 4 买入 买入
恒逸石化 4 买入 买入
南极电商 4 买入 买入
洽洽食品 4 持有 买入
贵州茅台 3 持有 买入
普洛药业 3 买入 买入
旗滨集团 3 买入 买入
喜临门 3 买入 买入
中南建设 3 买入 买入
比音勒芬 2 买入 持有
吉比特 2 持有 买入
完美世界 2 持有 买入
万科A 2 买入 买入
大悦城 2 买入 买入
美的集团 2 买入 买入
新经典 2 持有 中性

行业关注度

更多>>
行业名称关注度关注股票数买入评级数